Last updated: August 9, 2022
Sponsor: South Tees Hospitals NHS Foundation Trust
Overall Status: Active - Recruiting
Phase
N/A
Condition
Abnormal Blood Vessels (Arteriovenous Malformations)
Birth Defects
Holoprosencephaly
Treatment
N/AClinical Study ID
NCT05494710
248206
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- New patients presenting with a vascular malformation suitable for Bleomycinsclerotherapy treatment
- Existing patients presenting with a poor response to treatment, performed more than 6months ago
- Placement of a needle electrode into the vascular malformation is technically possible
- Evaluation of response to treatment is possible on photo documentation
- Patients agreeing to participate in the study
- The ability to understand written and spoken English
Exclusion
Exclusion Criteria:
- Patients not agreeing to participate in the study
- Pregnancy
- Breastfeeding
- Previous high systemic Bleomycin exposure (more than 3000 IU)
- Patients unable to provide written, informed consent
- Patients in which needle electrode placement is not possible
- Response to treatment not evaluable by photo documentation
- Patients unable to speak English
Study Design
Total Participants: 20
Study Start date:
December 01, 2020
Estimated Completion Date:
December 01, 2022
Connect with a study center
South Tees Hospitals NHS Foundation Trust
Middlesbrough, TS4 3BW
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.